Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Genomic Nanosystems Announces Exclusive Licensing Agreement to Sequenom for the Right to Use Digital PCR in Prenatal Testing and Mass Spectrometry
Genomic Nanosystems, LLC, today announced that it has granted an exclusive license to Sequenom, Inc. (Nasdaq: SQNM) for the right to use Digital PCR in noninvasive prenatal research and diagnostics on a technology, platform and sample independent basis, and has granted the exclusive right to use... - September 22, 2008 - Genomic Nanosystems
What is Tourette Syndrome?
Tourett Syndrome DNA Sharing Repository Helps Families Understand the Definition of TS. - September 21, 2008 - New Jersey Center for Tourette Syndrome
Tygon® Tubing Products Now Available from Professional Plastics
Professional Plastics, Inc. is now offering a full range of Tygon ® tubing products for fluid handling applications. Saint Gobain produces more than 40 grades of Tygon®, Tygothane®, Norprene®, Versilic ® and more. These products are sold online from www.professionalplastics.com/TYGONTUBING. - September 19, 2008 - Professional Plastics, Inc.
Free Webinar Helps Teachers Recognize Tourette Syndrome in the Classroom
Group behind the world's first TS DNA Sharing Repository aims to assist educators help children with Tourette Syndrome. - September 19, 2008 - New Jersey Center for Tourette Syndrome
BioScience Laboratories Tests Product Efficacy Against Clostridium Difficile Spores on Human Hands
BioScience Laboratories is one of the only facilities with the capability of testing a product’s efficacy when challenged with Clostridium difficile spores in vitro and now on human skin. BioScience Laboratories recently received approval from an independent institutional review board to test... - September 18, 2008 - BioScience Laboratories
TS DNA Sharing Repository Hosts State-of-the-art Treatment Talk About Tourette Syndrome and Associated Conditions
TS DNA Sharing Repository hosts a presentation on "State-of-the-art treatments for Tourette Syndrome and associated conditions" by Dr. Robert King as part of NJCTS ongoing genetic research project. - September 12, 2008 - New Jersey Center for Tourette Syndrome
Paper Reveals New Way to Combat Bioterror Agents
A new paper published in PLoS One, an international, peer-reviewed, open access, online publication by the Public Library of Science, have revealed an additional mechanism to neutralize Botuliimum neurotoxins (BoNTs). BoNTs are a family of toxins that cause the disease botulism, but they can also be used as bioterror agents that cause paralysis when they poison the neurons that transmit the signals responsible for breathing and muscular movement. - August 22, 2008 - Lankenau Institute for Medical Research
Aquatic Habitats Announces New Logo to Mark Recent Acquisition
Aquatic Habitats (AHAB), a world leader in aquatic housing solutions for the biomedical research community, announced today the launch of their new logo and tagline. These updates symbolize a new era for the company after the integration of Marine Biotech, Inc. AHAB's parent company, Aquatic... - August 20, 2008 - Aquatic Eco-Systems, Inc
Advanced 3D Imaging Summit for Dentistry to be Held in Columbus, Ohio
Due to the accelerated growth of dental 3D imaging in the Ohio Valley region, on September 5th, 2008, the first comprehensive, regional summit will be held in Columbus, Ohio. Eight renowned speakers will discuss how 3D imaging has impacted the level of care they provide to their patients. The Ohio 3D Summit will offer dental professionals the possibility to learn from their peers in an educational environment. To register, please call Bev Reeder from Patterson Dental at 614-791-9141. - July 25, 2008 - Sirona Dental Systems
6 Year Old Son's Parents Proactively Raise Money for Diabetes Research and Care by Forming AdamsCure.Org, a Non-Profit and Providing Concerts and Various Entertainment
AdamsCure.Org is about providing a service in the form of quality entertainment to raise money for diabetes research and care. Concerts will run about a month apart. In addition to musical entertainment, they plan to have comedy acts, talent shows, bull roasts, crab feasts, golf tournaments, etc. Ticket prices are extremely fair and available by calling 877-725-8849 or by visiting their web site at www.adamscure.org. - July 23, 2008 - AdamsCure.Org
End Malaria – Blue Ribbon Campaign, Welcomed at European Meeting
Dr. Mary Galinski, Founder and President of the Malaria Foundation International, attended the International Conference on Malaria held April 21-22 in Bonn, Germany: Joining Forces, Synergizing Action, Sustainable and innovative ways of ensuring long-term prevention and treatment measures by 2015. The MFI's End Malaria - Blue Ribbon pins were welcomed at the meeting. - July 22, 2008 - Malaria Foundation International
Studies Show Hope for Reversing Trend in People with Type 2 Diabetes
Number of People with Diabetes Increases to 24 Million according to new 2007 prevalence data estimates released by the Centers for Disease Control and Prevention (CDC). Studies show hope for reversing trend in people with T2 diabetes and metabolic syndrome using carbohydrate restricted diet. - July 03, 2008 - Nutrition & Metabolism Society
Reading for Cancer - Novelist Donates Book
New novel by author Michael Raymond intended to launch a new fundraising concept - Read a book for Cancer. Revenues from sales are donated to Cancer Society and readers urged to donate as well and pass book along. - July 01, 2008 - Michael Raymond
Trippy Trilogy - Alive Mind's Altered Consciousness Collection
3 Acclaimed Documentaries Coming to DVD. - June 24, 2008 - Alive Mind
Russ Allen Reports Link Found Between Electrical Pollution and Autism in Children
Since the 1990s, autism has become the fastest-growing developmental disability in the United States. With numbers on an annual rise, it has been estimated that one in every 150 births (24,000 newborns a year) will be diagnosed with autism. - June 14, 2008 - Glenmore Books
LabSource, Inc. Introduces Its New BioFlash Catalog
LabSource Inc. is pleased to announce the immediate availability of its new Summer 2008 BioFlash catalog with products for the life science laboratory. This all-new, full-color BioFlash features laboratory products including disposable gloves and protective clothing, labels, pipettes, tips, PCR... - June 12, 2008 - LabSource, Inc.
Public Awareness, Acute Aortic Syndrome (AAS)
Acute Aortic Syndrome Research Program, a student organization at University of California, Los Angeles (UCLA) and the only student organization at Cedars-Sinai Medical Center (CSMC) has launched a public awareness campaign to educate the public in regards with Acute Aortic Syndrome (AAS) a newly... - May 31, 2008 - Acute Aortic Syndrome Research Program @ UCLA
NuU Medspa Join the Mission to March for Babies®; NuU Participate in Raising Awareness for March of Dimes®
NuU Medspa has devoted their efforts to The 39th Annual March for Babies held on Saturday, April 19, 2008 at the Wesley Bolin Plaza, AZ. The March of Dimes® Walk heightens awareness and funds for the prevention of premature birth – the leading cause of newborn death and healthy... - May 28, 2008 - NuU Unlimited
3rd Annual American Cancer Society Coral Gables Relay for Life Silent Auction and Fashion Show
In joyous culmination and tasteful celebration of a successful Coral Gables Relay of Life 2008, this year they are hosting the Third Annual Relay for Life Silent Auction and Fashion Show. At 6:30pm on Thursday, May 22nd at the Venetian Pool in Coral Gables; survivors, family, friends, supporters, volunteers and community members will assemble to the theme of Old Havana. All proceeds from this event will benefit the Coral Gables American Cancer Society Relay for Life. - May 18, 2008 - Coral Gables Relay for Life
Global Dialysis Care Products and Services Market to Top $69 Billion by 2010: Marketstrat
The world market for end-stage renal disease dialysis devices and services is expected to reach $64.5 billion by the end of 2008, according to a new report titled, “End-Stage Renal Disease (ESRD) Dialysis Devices & Services Worldwide.” - May 12, 2008 - Marketstrat
Integrated Clinical Trial Services Exhibits at Bio 2008
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS) (www.integratedtrials.com), a company providing innovative and efficient patient-oriented solutions to the clinical research industry, has announced that the firm will be exhibiting at the 2008 Bio International Convention, June... - May 04, 2008 - Integrated Clinical Trial Services
Research Night on Gender and Multiple Sclerosis Scheduled for May 15
The Eastern North Carolina Chapter of the National Multiple Sclerosis Society will host the Tenth Annual MS Research Night on Thursday, May 15 at the Marriott Raleigh Crabtree Valley. This year’s speaker, Dr. Caroline Whitacre, will be discussing the effects of gender on MS, specifically... - May 01, 2008 - National MS Society - Eastern North Carolina Chapter
Changes in the Field of Revision Rhinoplasty
There are many changes going on in the field of revision rhinoplasty that will impact patients and doctors alike in the near future. - April 30, 2008 - Institute for Rhinoplasty and Nasal Reconstruction
Four Teens Fully Recover from Autism
Press Conference and World Premiere Movie. - April 25, 2008 - Center for Autism and Related Disorders
MakroCare: Oracle Clinical Implementation
MakroCare announces the completion of Oracle Clinical implementation to strengthen its Clinical Data Management services. This implementation will help the company in creating a faster data management solution, which improves time lines and optimizes the cost of the clinical trial. MakroCare has... - April 23, 2008 - MakroCare
North Carolina Researchers Awarded Grant to Propel Multiple Sclerosis Research
Grants part of ongoing collaboration between the University of North Carolina at Chapel Hill and the National MS Society. - April 11, 2008 - National MS Society - Eastern North Carolina Chapter
Plymouth Pharmaceuticals and Dermatologist Cited in ‘Skin and Allergy News’ Regarding Drug’s (Acunol™) Role in Preventing Jewelry Allergy
The respected journal “Skin & Allergy News” recently released “Nickel Named Contact Allergen of the Year” in its current issue. Researcher Dr Katherine A Zug, of the Department of Dermatology at Dartmouth Hitchcock Medical Center in Lebanon, NH, has published her... - April 10, 2008 - Plymouth Pharmaceuticals Inc
ClinfoSource and Nucleus Network Jointly Launch On-Line GCP Clinical Trials Training Programs for the Australia-New Zealand Region
ClinfoSource, a US-based global online training company has partnered with Nucleus Network of Australia to provide web-based GCP training for clinical trials professionals in the Australia region, later to be extended to include New Zealand regulations. This program will offer clinical trial investigators, coordinators, research associates and others a solid and practical understanding of clinical trials conduct and management, the regulations and ethics central to the drug development process. - February 28, 2008 - ClinfoSource
The Hamner Institutes for Health Sciences Receives Funding to Study Inhalation Toxicity of Jet Fuel
The Hamner Institutes for Health Sciences (www.thehamner.org), has announced that Dr. Darol E. Dodd, a senior research toxicologist at CIIT and director of toxicology and preclinical studies at The Hamner, has received a $655,367 contract from the Navy Health Research Center – Environmental... - February 28, 2008 - The Hamner Institutes for Health Sciences
Vascular BioSciences Awarded Phase 1 STTR Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Pulmonary Hypertension Research
Vascular BioSciences announced today it has received a STTR Phase 1 grant from the National Heart Lung Blood Institute of the National Institutes of Health in the amount of $165,745. The STTR award, “Targeting Pulmonary Hypertension with R-Ras,” will be performed in collaboration with... - February 10, 2008 - Vascular BioSciences, Inc
Transinsight’s GoPubMed with Social Networking Features for Biomedical Experts
GoPubMed now allows users to identify experts in the biomedical field and gain important information on recent research topics by viewing their networks. - January 11, 2008 - Transinsight
Integrated Clinical Trial Services Releases Podcast on Patient Study Compliance
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a company providing innovative and efficient patient-oriented recruitment solutions to the clinical research industry, has announced the release of a podcast discussing effective strategies to incorporate patient-study compliance... - January 07, 2008 - Integrated Clinical Trial Services
Cardiovascular Sciences, Inc. Announces Funding Event
Cardiovascular Sciences, Inc. (CVSC), a corporation under the laws of Nevada, is excited to reveal an initial funding event with Seven Palm Investments, LLC of Illinois. After a recent assessment and restructuring of the company’s equity, the company and its investors are ready to move ahead... - December 12, 2007 - Cardiovascular Sciences, Inc.
Integrated Clinical Trial Services Releases Podcast on Patient Recruitment
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a firm that provides innovative and efficient patient-oriented recruitment solutions to the clinical research industry, has announced the release of a podcast discussing patient recruitment as a classic marketing problem. In the... - December 04, 2007 - Integrated Clinical Trial Services
The Hamner Institutes For Health Sciences Names Chief Business Officer
The Hamner Institutes for Health Sciences (www.thehamner.org), an independent, nonprofit organization that offers an open, collaborative and cross-disciplinary approach to translational biomedical research, announced that Rick Williams has joined the organization as chief business officer. As a... - December 03, 2007 - The Hamner Institutes for Health Sciences
The Hamner Institutes for Health Sciences Announces New Research Investigator
Dr. William F. Greenlee, president and CEO of The Hamner Institutes For Health Sciences, an independent, nonprofit organization that offers an open, collaborative and cross-disciplinary approach to translational research to enhance the value of the investment in biomedical sciences, has announced... - November 28, 2007 - The Hamner Institutes for Health Sciences
Dr. Thomas Klaue, CFO of Medigene AG Has Been Selected for Inclusion in the 2007-2008 Princeton Premier Registry
Dr. Thomas Klaue, CFO of Medigene AG has been selected for inclusion in the 2007-2008 Princeton Premier Registry. Before joining MediGene, Dr. Klaue has been a partner at Fozzati Partners LLC, Frankfurt, a private investment bank where he acted as an advisor on business transactions for major... - November 27, 2007 - Princeton Premier
The Hamner Institutes for Health Sciences Partners with EPA
The Hamner Institutes for Health Sciences (www.thehamner.org) has signed a memorandum of understanding (MOU) with the U.S. Environmental Agency’s (EPA) National Center for Computational Toxicology (NCCT). The agreement establishes a one-year collaborative research effort to further the... - November 20, 2007 - The Hamner Institutes for Health Sciences
The Hamner Institutes for Health Sciences Receives $970,000 Grant for Interpreting Biomonitoring Data
The Hamner Institutes for Health Sciences, an independent, nonprofit organization that offers an open, collaborative and cross-disciplinary approach to translational research to enhance the value of the investment in biomedical sciences, has announced that Dr. Harvey Clewell, director of the Center... - November 06, 2007 - The Hamner Institutes for Health Sciences
NCSRT Introduces WORKS™, an Integrated Program of Products, Applications Guides, Optimization Tools, and Services
NCSRT Introduces WORKS™, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow™ TFF modules and industry leading PUROSEP®... - October 30, 2007 - NCSRT, Inc.
Linda De Caprio Has Been Selected for Inclusion in the 2007-2008 Princeton Premier Registry of Business Leaders and Professionals
Linda De Caprio has been selected for inclusion in the 2007-2008 Princeton Premier Registry of Business Leaders and Professionals. Linda is currently a Director and Clinical Program Leader for Johnson and Johnson with her personal expertise in cardiovascular research and global project management. - October 25, 2007 - Princeton Premier
Epidemic of Anesthesia Overdosing… How Can You Avoid It?
“Most patients tolerate their anesthetic experience despite the care they receive rather than because of it,” claims Dr. Barry Friedberg, holder of the trademark “minimally invasive anesthesia (MIA).®” - October 23, 2007 - Barry L. Friedberg, M.D., Cosmetic Surgery Anesthesia
The Hamner Institutes for Health Sciences Receives $1.6 Million NIH Grant
Dr. William F. Greenlee, president and CEO of The Hamner Institutes for Health Sciences, an independent, nonprofit organization that offers an open, collaborative and cross-disciplinary approach to strengthen the research investment in biomedical sciences, has announced that Dr. Wenhong Cao,... - October 19, 2007 - The Hamner Institutes for Health Sciences
INVEGA™ Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL® in Acutely Ill Hospitalized Patients
In a comparison study between schizophrenia treatments INVEGA™ (paliperidone) Extended-Release Tablets and SEROQUEL® (quetiapine), Invega patients saw schizophrenia symptom improvements as early as five days into therapy and continued through the end of the two-week study period. Results were presented today at the 20th Annual U.S. Psychiatric and Mental Health Congress in Orlando, Florida. - October 13, 2007 - Johnson & Johnson
Dr. William Heyward on the Forefront of the Fight Against the World's Deadliest Communicable Diseases
For nearly three decades, William Heyward has been on the forefront in the fight against some of the world's deadliest communicable diseases. HIV/AIDS, Ebola, haemophilius influenzae, hepatitis B, and hepatic cancer are among the many illnesses he has focused his attention on in places as far-flung as Zaire, Alaska, South America and Thailand. Dr. Heyward has lived on the leading edge of research on the causes, effects and prevention of devastating diseases among some of the world's poorest area - October 12, 2007 - William Heyward
The Hamner Institutes for Health Sciences Launches Web Site
Dr. William F. Greenlee, president and CEO of The Hamner Institutes For Health Sciences, an independent, nonprofit organization that offers an open, collaborative and cross-disciplinary approach to translational research to enhance the value of the investment in biomedical sciences, has announced... - October 12, 2007 - The Hamner Institutes for Health Sciences
The Hamner Institutes for Health Sciences Receives Grant for Diabetes Research
Dr. William F. Greenlee, president and CEO of The Hamner Institutes for Health Sciences, has announced that Dr. Jingbo Pi, research investigator in the Division of Translational Biology at The Hamner, has been awarded $415,000 over a three-year period from the National Institutes of Health (NIH). - October 05, 2007 - The Hamner Institutes for Health Sciences
The Hamner Institutes for Health Sciences Receives Grant for Cancer Prevention Research
Dr. William F. Greenlee, president and CEO of The Hamner Institutes for Health Sciences, has announced that Dr. Sheela Sharma, senior research investigator in the Preclinical Prevention Research Program at The Hamner, has been awarded $450,000 over a period of 18 months from the National Cancer Institute and the University of Alabama at Birmingham. - September 26, 2007 - The Hamner Institutes for Health Sciences
CureHunter Deploys "Machine 2nd Opinion"- Research Interface for Doctors
CureHunter Opens Research Interface Beta to Doctors Free of Charge and Revolutionizes Practice of Evidence Based Medicine in Real-Clinical-Time - September 21, 2007 - CureHunter Inc.
Sleep Study Suggests Magnetic Sleep Machine Promotes Deeper Sleep and Reduces Fibromyalgia Pain
Somnogram shows Sleep on Command™ Delta-rhythm magnetic signals help promote slow-wave, Delta-stage sleep throughout the night resulting in remarkable daytime pain relief in subject with fibromyalgia pain. - August 20, 2007 - EarthPulse Tech, LLC